These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 27184426)

  • 1. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
    Waghray M; Yalamanchili M; Dziubinski M; Zeinali M; Erkkinen M; Yang H; Schradle KA; Urs S; Pasca Di Magliano M; Welling TH; Palmbos PL; Abel EV; Sahai V; Nagrath S; Wang L; Simeone DM
    Cancer Discov; 2016 Aug; 6(8):886-99. PubMed ID: 27184426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo.
    Meng MY; Li L; Wang WJ; Liu FF; Song J; Yang SL; Tan J; Gao H; Zhao YY; Tang WW; Han R; Zhu K; Liao LW; Hou ZL
    J Cancer Res Clin Oncol; 2019 May; 145(5):1133-1146. PubMed ID: 30805774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.
    Cantero MJ; Bueloni B; Gonzalez Llamazares L; Fiore E; Lameroli L; Atorrasagasti C; Mazzolini G; Malvicini M; Bayo J; García MG
    Stem Cell Res Ther; 2024 Jul; 15(1):208. PubMed ID: 38992782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.
    Borghese C; Casagrande N; Pivetta E; Colombatti A; Boccellino M; Amler E; Normanno N; Caraglia M; De Rosa G; Aldinucci D
    Oncotarget; 2017 Jun; 8(26):42926-42938. PubMed ID: 28477013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition.
    Zhou HS; Su XF; Fu XL; Wu GZ; Luo KL; Fang Z; Yu F; Liu H; Hu HJ; Chen LS; Cai B; Tian ZQ
    Oncotarget; 2016 Jul; 7(27):41294-41305. PubMed ID: 27191496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
    Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
    Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cells Promote Pancreatic Tumor Growth by Inducing Alternative Polarization of Macrophages.
    Mathew E; Brannon AL; Del Vecchio A; Garcia PE; Penny MK; Kane KT; Vinta A; Buckanovich RJ; di Magliano MP
    Neoplasia; 2016 Mar; 18(3):142-51. PubMed ID: 26992915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.
    Pylayeva-Gupta Y; Lee KE; Hajdu CH; Miller G; Bar-Sagi D
    Cancer Cell; 2012 Jun; 21(6):836-47. PubMed ID: 22698407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy.
    Plava J; Cihova M; Burikova M; Bohac M; Adamkov M; Drahosova S; Rusnakova D; Pindak D; Karaba M; Simo J; Mego M; Danisovic L; Kucerova L; Miklikova S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion.
    Cho H; Seo Y; Loke KM; Kim SW; Oh SM; Kim JH; Soh J; Kim HS; Lee H; Kim J; Min JJ; Jung DW; Williams DR
    Clin Cancer Res; 2018 Nov; 24(21):5407-5421. PubMed ID: 29959142
    [No Abstract]   [Full Text] [Related]  

  • 15. An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer.
    Chen Y; Zhao Z; Chen Y; Lv Z; Ding X; Wang R; Xiao H; Hou C; Shen B; Feng J; Guo R; Li Y; Peng H; Han G; Chen G
    Sci Rep; 2017 Aug; 7(1):8265. PubMed ID: 28811578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.
    Reggiani F; Labanca V; Mancuso P; Rabascio C; Talarico G; Orecchioni S; Manconi A; Bertolini F
    Cancer Res; 2017 Sep; 77(18):5169-5182. PubMed ID: 28754674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow.
    Hofer EL; Labovsky V; La Russa V; Vallone VF; Honegger AE; Belloc CG; Wen HC; Bordenave RH; Bullorsky EO; Feldman L; Chasseing NA
    Stem Cells Dev; 2010 Mar; 19(3):359-70. PubMed ID: 19388812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling.
    Secq V; Leca J; Bressy C; Guillaumond F; Skrobuk P; Nigri J; Lac S; Lavaut MN; Bui TT; Thakur AK; Callizot N; Steinschneider R; Berthezene P; Dusetti N; Ouaissi M; Moutardier V; Calvo E; Bousquet C; Garcia S; Bidaut G; Vasseur S; Iovanna JL; Tomasini R
    Cell Death Dis; 2015 Jan; 6(1):e1592. PubMed ID: 25590802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal liver stromal cells support blast growth in transient abnormal myelopoiesis in Down syndrome through GM-CSF.
    Miyauchi J; Kawaguchi H
    J Cell Biochem; 2014 Jun; 115(6):1176-86. PubMed ID: 24415393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.